Albrecht; Janice K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Albrecht; Janice K..The latest application filed is for "markers associated with ribavirin-induced anemia".

Company Profile

0.5.9

Albrecht; Janice K. - Winter Park FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Markers Associated With Ribavirin-induced Anemia App 20120282224 - Albrecht; Janice K. ; et al.	2012-11-08
Method Of Treating Hepatitis C Patients App 20100226885 - Albrecht; Janice K. ; et al.	2010-09-09
Method of treating interferon non-responders using HCV protease inhibitor App 20070004635 - Albrecht; Janice K. ; et al.	2007-01-04
Methods of treating hepatitis C virus App 20060276407 - Albrecht; Janice K. ; et al.	2006-12-07
Methods for treating hepatitis C App 20060276405 - Albrecht; Janice K.	2006-12-07
Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20060257365 - Albrecht; Janice K.	2006-11-16
Ribavirin-pegylated interferon alfa induction HCV combination therapy Grant 6,824,768 - Stalgis , et al. November 30, 2	2004-11-30
Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20030039630 - Albrecht, Janice K.	2003-02-27
Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection Grant 6,472,373 - Albrecht October 29, 2	2002-10-29
Ribavirin-pegylated interferon alfa HCV combination therapy App 20020127203 - Albrecht, Janice K.	2002-09-12
Ribavirin-pegylated Interferon Alfa Induction Hcv Combination Therapy App 20020119122 - STALGIS, CARLOS O. ; et al.	2002-08-29
Combination therapy for chronic hepatitis C infection Grant 6,387,365 - Albrecht , et al. May 14, 2	2002-05-14
Combination therapy for chronic hepatitis c infection Grant 6,299,872 - Albrecht , et al. October 9, 2	2001-10-09
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection Grant 6,172,046 - Albrecht January 9, 2	2001-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.